Diamox SR (Sustained Release) is a prescription medication primarily used to treat certain types of glaucoma, a condition characterized by increased pressure in the eye, which can lead to vision loss. It is also used to manage and prevent symptoms of acute mountain sickness (AMS), which affects individuals when they ascend to high altitudes too quickly. Additionally, Diamox SR is prescribed for the treatment of specific types of seizures and edema (fluid retention) when other treatments have not been effective. The active ingredient in Diamox SR is acetazolamide, which belongs to a class of drugs known as carbonic anhydrase inhibitors. This medication works by reducing the production of fluid in the eye and increasing the excretion of bicarbonate in the urine, thereby helping to lower blood pressure in the eye and adjust the body's acid-base balance. The sustained-release formulation allows for a more consistent release of the medication over time, potentially reducing side effects and improving patient compliance with the treatment regimen.
Your cart contains products from a separate order category. Adding this product will remove those items from your cart.
Important Supply & Pricing Update about GLP-1 Medications
Due to manufacturer-driven price increases from Eli Lilly and other suppliers, prices for GLP-1 medications including Mounjaro have risen significantly. Global supply constraints may also result in slightly longer lead times.
We remain committed to securing the best possible pricing and supply for our customers and will continue to provide updates as the situationĀ evolves.